Tetra Bio-Pharma (TBPMF) Cash & Debt
Tetra Bio-Pharma (TBPMF) has $73.0M in cash and equivalents with $384.2M in total debt, resulting in a net cash position of -$311.2M. Estimated cash runway is approximately 37 months.
Cash & Equivalents
$73.0M
Total Debt
$384.2M
Net Cash
-$311.2M
Cash Runway
37 mo
Quarterly Balance Sheet
No balance sheet data available for TBPMF.
Frequently Asked Questions
How much cash does TBPMF have?+
Cash and equivalents for Tetra Bio-Pharma includes cash in bank accounts, money market funds, and short-term investments that can be quickly converted to cash. This figure comes from the company's most recent quarterly balance sheet filing.
What is Tetra Bio-Pharma's debt situation?+
Total debt includes all short-term and long-term borrowings reported on the balance sheet. Cannabis companies often carry higher debt loads because limited access to traditional banking forces them to use alternative financing at higher interest rates. Compare TBPMF's debt-to-equity ratio to industry peers for context.
How long can TBPMF operate at its current burn rate?+
Cash runway is estimated by dividing cash on hand by the average monthly cash burn (negative operating cash flow). For Tetra Bio-Pharma, this metric indicates how many months the company can continue operating without raising additional capital. Companies with less than 12 months of runway may need to raise capital soon, which could dilute shareholders.